CD14 dim CD16 + and CD14 + CD16 + Monocytes in Obesity and During Weight Loss
Author(s) -
Christine Poitou,
Élise Dalmas,
Mariana RenovatoMartins,
Vanessa Benhamo,
Froogh Hajduch,
Mériem Abdennour,
Jean-François Kahn,
Nicolas Veyrie,
Salwa W. Rizkalla,
Wolf H. Fridman,
Catherine SautèsFridman,
Karine Clément,
Isabelle Cremer
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.230979
Subject(s) - cd14 , cd16 , monocyte , medicine , endocrinology , obesity , biology , weight loss , immunology , flow cytometry , antigen , cd3 , cd8
Studies suggest the implication of CD16(+) subpopulations (CD14(+)CD16(+), CD14(dim)CD16(+)) in inflammatory diseases. We aimed to determine the frequency of these subpopulations during weight loss in obesity and diabetes, conditions associated with changes in systemic inflammation, and we tested the link with subclinical atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom